NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/20/2025
Back to search
Official data from USPTO
CELLPREP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/13/2026
Trademark type
Word
Nice classes
10
Filing date
04/04/2014
Registration date
01/12/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2025
Last transaction
01/13/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Gyeonggi-do, KR
Examiner
PAQUIN,SAMUEL ROBERT
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BIODYNE CO., LTD.
Representatives
James E. Bame IPLA P.A.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus for examining gynecological body fluidfine needle aspiration (FNA)respiratory tractcerebrospinal fluid specimens; Cytological specimen preparation devices for medical diagnosis; Medical apparatus for analyzing cervical body fluidfine needle aspiration (FNA)respiratory tracturinecerebrospinal fluid specimens; Hematology analyzers for medical diagnostic uses; Pathology analyzers for medical diagnostic uses; Immunohistochemistry (IHC) analyzers for medical diagnostic uses; Medical apparatus used for In Vitro Diagnostics (IVD); Medical analyzers used for molecular diagnosis; Medical apparatus for analyzing human papilloma virus (HPV); Medical apparatus for detecting microorganisms in the human body; Medical diagnostic apparatus for cytopathology
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/20/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/20/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/19/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/12/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/12/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/13/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/13/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2022
E815
TEAS SECTION 8 & 15 RECEIVED
12/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2016
PUBO
PUBLISHED FOR OPPOSITION
10/27/2015
NPUB
NOTICE OF PUBLICATION
10/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/18/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2015
ALIE
ASSIGNED TO LIE
09/04/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/21/2015
CNSL
LETTER OF SUSPENSION MAILED
04/22/2015
CNSL
SUSPENSION LETTER WRITTEN
04/21/2015
NREV
NOTICE OF REVIVAL - MAILED
04/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2015
PETG
PETITION TO REVIVE-GRANTED
04/09/2015
PROA
TEAS PETITION TO REVIVE RECEIVED
04/09/2015
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
02/12/2015
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02/12/2015
CNRT
NON-FINAL ACTION MAILED
07/14/2014
CNRT
NON-FINAL ACTION WRITTEN
07/12/2014
DOCK
ASSIGNED TO EXAMINER
07/12/2014
MPMK
NOTICE OF PSEUDO MARK MAILED
04/18/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2014
NWAP
NEW APPLICATION ENTERED
04/08/2014
Continuous trademark protection
Get notified about every new filing that threatens CELLPREP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.